Statistics

Total Visits

Views
Open label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: The Greko II study-GETHI 2013-01.74

Select a period of time:

Number of views in the range

Views
Open label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: The Greko II study-GETHI 2013-01.12

Views

Views
December 20250
January 20261
February 20260
March 20261
April 20261
May 20262
June 20267
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States3
Paraguay2
Argentina2
Colombia1
Honduras1
Singapore1
Turkey1
Venezuela1
 

Top cities views

Views
Ankara1
Buenos Aires1
Caaguazú1
La Plata1
Muscatine1
Villavicencio1
Winter Springs1
Yonkers1